
Sunday, January 20, 2019 2:32:41 PM
https://www.siliconinvestor.com/readmsg.aspx?msgid=31986568

Liked By
Spread the love. Be the first to like this post!
Recent NANO News
- INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL • Business Wire • 08/09/2022 08:15:00 PM
- Voting Rights and Shares Capital of the Company • Business Wire • 08/09/2022 08:15:00 PM
- Half-year Report on the Nanobiotix Liquidity Contract With Gilbert Dupont • Business Wire • 07/13/2022 08:15:00 PM
- BILAN SEMESTRIEL 2022 DU CONTRAT DE LIQUIDITÉ NANOBIOTIX AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT • Business Wire • 07/13/2022 08:15:00 PM
- Nanobiotix: Voting Rights and Shares Capital of the Company • Business Wire • 07/08/2022 08:15:00 PM
- Nanobiotix : INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL • Business Wire • 07/08/2022 08:15:00 PM
- INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL • Business Wire • 06/09/2022 08:15:00 PM
- Statement of Total Voting Rights and Shares Forming the Company’s Share Capital • Business Wire • 06/09/2022 08:15:00 PM
- New Data Featuring NBTXR3 Plus Chemoradiation and in the Preoperative Setting Support Broad Applicability for Head and Neck Cancer and Other Solid Tumor Indications • Business Wire • 06/05/2022 01:00:00 PM
- DE NOUVELLES DONNÉES ASSOCIANT NBTRX3 AVEC LA CHIMIOTHÉRAPIE EN PRÉOPÉRATOIRE INDIQUENT QUE NBTRX3 S’INTEGRERAIT DANS LE TRAITEMENT DU CANCER DE LA TÊTE ET DU COU ET D'AUTRES TUMEURS SOLIDES • Business Wire • 06/05/2022 01:00:00 PM
- NANOBIOTIX Annual Shareholders’ General Meeting to Be Held on June 23, 2022 • Business Wire • 06/02/2022 08:15:00 PM
- L’ASSEMBLÉE GÉNÉRALE MIXTE ANNUELLE DE NANOBIOTIX SE TIENDRA LE 23 JUIN 2022 • Business Wire • 06/02/2022 08:15:00 PM
- CORRECTING and REPLACING: NANOBIOTIX Provides First Quarter Operational and Financial Update • Business Wire • 05/19/2022 01:12:00 AM
- NANOBIOTIX FAIT LE POINT SUR SES ACTIVITÉS ET PUBLIE SES RÉSULTATS FINANCIERS POUR LE PREMIER TRIMESTRE • Business Wire • 05/19/2022 01:12:00 AM
- NANOBIOTIX FAIT LE POINT SUR SES ACTIVITÉS ET PUBLIE SES RÉSULTATS FINANCIERS POUR LE PREMIER TRIMESTRE • Business Wire • 05/18/2022 08:40:00 PM
- NANOBIOTIX Provides First Quarter Operational and Financial Update • Business Wire • 05/18/2022 08:40:00 PM
- NANOBIOTIX to Present During the Jefferies Healthcare Conference in June 2022 • Business Wire • 05/17/2022 08:15:00 PM
- NANOBIOTIX PARTICIPERA EN JUIN À LA CONFÉRENCE JEFFERIES HEALTHCARE • Business Wire • 05/17/2022 08:15:00 PM
- NANOBIOTIX to Participate in Two Upcoming Investor Conferences • Business Wire • 05/11/2022 08:15:00 PM
- NANOBIOTIX PARTICIPERA PROCHAINEMENT À DEUX CONFÉRENCES INVESTISSEURS • Business Wire • 05/11/2022 08:15:00 PM
- Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital • Business Wire • 05/10/2022 08:15:00 PM
- INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL • Business Wire • 05/10/2022 08:15:00 PM
1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition • CBDW • Jan 27, 2023 11:59 AM
IQST - iQSTEL Reminds Shareholders To Get Their Votes In Before Annual Meeting Next Week On January 31, 2023 • IQST • Jan 26, 2023 9:53 AM
Nextech AR's AI-Powered CAD to Poly Toggle3D Launches Major Technology Advancements • ARWYF • Jan 26, 2023 8:46 AM
UCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023 • UCASU • Jan 26, 2023 7:21 AM
Kaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market • KAYS • Jan 25, 2023 10:53 AM
B2 Digital's B2 SPORTS NETWORK (B2SN) Expands Distribution to Europe, Russia, and Asia with StayLIVE Agreement • BTDG • Jan 25, 2023 10:00 AM